Chief Physician 

Professor

Doctoral Supervisor

Lifetime Honorary Professor of Zhongshan Hospital, Fudan University

Dr. Bai currently serves as the Director of the Shanghai Respiratory Research Institute, Director of the Shanghai Engineering Research Center of Internet of Things for Respiratory Medicine, Chairman of the International Association for Metaverse in Medicine (IAMM), Chairman of the Chinese Alliance Against Lung Cancer, and President of the Shanghai Association of Tobacco Control.

Besides, he also serves as the Editor-in-Chief for "Metaverse in Medicine", "Clinical e-Health", and "Frontiers in Medicine" in the respiratory research section, and as the Associate Editor for the "American Journal of Physiology-Lung Cellular and Molecular Physiology."

Dr. Bai has led numerous major and key projects funded by the National Natural Science Foundation of China, held 46 authorized patents, and led the development of 30 domestic and international consensus guidelines. He has published over 700 academic papers, including more than 300 SCI articles, with nearly 20,000 citations and an h-index of 55. He has edited 10 monographs in both Chinese and English, including "The Future is Now -The Metaverse Medicine We Need", "Internet of Things in Medicine", and "Modern Respiratory Medicine".

Dr. Bai has received several honors and awards, including the Second Prize of National Science and Technology Progress Award, the First Prize of Chinese Medical Science and Technology Award, and the Asia Pacific Society of Respirology Medal.

Chief Physician

Professor

Doctoral Supervisor

Secretary of the Party Committee, Zhongshan Hospital, Fudan University

Dr. Gu currently serves as a member of the Chinese Society of Plastic Surgery of the Chinese Medical Association, a standing committee member of the Aesthetic and Plastic Surgery Branch of the Chinese Medical Doctor Association, the Deputy Chairperson of the Plastic and Aesthetic Committee of the China Medical Women's Association, Vice President of the Chinese Association of Plastic and Aesthetic Surgery, Deputy Chairperson of the Plastic Surgery Branch of the Shanghai Medical Association, Deputy Chairperson of the Aesthetic and Plastic Surgery Branch of the Shanghai Medical Doctor Association, Deputy Editor-in-Chief of the 7th Editorial Board of the “Chinese Journal of Plastic Surgery”, Deputy Editor-in-Chief of “Annals of Plastic Surgery”, and a board member of “Chinese Journal of Plastic and Reconstructive Surgery (English Edition)”.

Dr. Gu is engaged in projects such as building a comprehensive quality control and management system for precision medicine, developing big data and artificial intelligence applications in smart hospital construction, and establishing a 5G-integrated medical imaging collaboration platform for hospital alliances.

Member, German National Academy of Sciences (Leopoldina) 

Clarivate Highly Cited Researcher (2022, Cross-Field) 

Founding Director, Digital Health Center, Berlin Institute of Health (BIH)  

Roland Eils is an internationally renowned computational biologist and research strategist who has held key leadership positions at major German research institutions, including the German Cancer Research Center (DKFZ) and Heidelberg University. He has founded and led several national-level scientific platforms, such as the BIOQUANT Center for Quantitative Biology at Heidelberg University (comprising over 250 scientists), the German Medical Informatics Alliance HiGHmed (integrating 14 university medical centers), and the GAIA-X Health Data Cloud Infrastructure project. Eils is a pioneer in health big data and AI-driven medicine. His groundbreaking research includes the creation of the world’s first human pancreatic cell atlas and the SARS-CoV-2 infection mechanism map (cited over 1,200 times), as well as leadership in the International Cancer Genome Consortium’s computational core. More recently, he has made key advances in AI-based disease risk prediction and the evaluation of clinical large language models.

Eils has published over 700 scientific papers (330 in the past decade), with more than 86,000 total citations and an H-index of 120. Over 30 of his papers have appeared in leading journals such as Cell and Nature. He is the recipient of prestigious honors including the German BioFuture Award and is frequently invited to lecture at world-class institutions such as Harvard and Oxford. Beyond academia, he is deeply engaged in research translation and innovation, currently serving as CEO of the European Health Data Alliance. His bioinformatics tools, including R packages with over two million global downloads, are widely used in biomedical research. As the Executive Dean of the Institute of Intelligent Medicine at Fudan University, he aims to leverage his international leadership experience and cutting-edge expertise in intelligent medicine to establish the institute as a global hub of innovation and excellence.

Professor

Doctoral Supervisor

Academician of Chinese Academy of Sciences

Currently, Professor Yang serves as the Director of the Academic Committee of the Institutes of Brain Science at Fudan University, Deputy Editor-in-Chief of Cihai, and Editorial Board Member of Progress in Neurobiology.

He has previously held positions such as Director of the Shanghai Institute of Physiology, Director of the Institute of Neurobiology at Fudan University, Dean of the Institutes of Brain Science at Fudan University, Chairman of the Chinese association for Physiological Sciences, Editor-in-Chief of Acta Physiologica Sinica and Neuroscience Bulletin, Editorial Board Member of Journal of Physiological Sciences, Secretary-General of the Federation of the Asian and Oceanian Physiological Societies, and Chief Scientist of the National Key Basic Research Program of China -- Basic Research on Brain Function and Major Brain Diseases.

Professor 

Doctoral Supervisor 

Academician of the Chinese Academy of Engineering 

Dr. Zhong, one of the first national-level experts with outstanding contributions, has been appointed successively as a special member of the American Thoracic Society and a member of the Asia-Pacific Executive Committee. 

He currently serves as the Vice Chairman of the Medical and Health Engineering Division of the Chinese Academy of Engineering, Vice Chairman of the Guangdong Provincial Association for Science and Technology, and Chairman of the Guangzhou Association for Science & Technology. 

In addition, Dr. Zhong also serves as a chairman of the editorial board of the "Chinese Journal of Tuberculosis and Respiratory Diseases", and vice chairman of the editorial board of the "Chinese Journal of Internal Medicine".

Professor Pan is currently a Fellow of the American Institute for Medical and Biological Engineering, a Fellow of the European Academy of Sciences and Arts, a Foreign Member of the Russian Academy of Engineering, a Foreign Member of the Engineering Academy of Ukraine, and a Fellow of the Royal Society for Public Health in the UK. He is also the Dean and Chair Professor of the School of Computer Science and Control Engineering at the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences.

Professor Pan's main research areas include using tools such as cloud computing, big data analysis, artificial intelligence, and deep learning to conduct research in bioinformatics and medical informatics.

Dr. Song is the Deputy Director of Zhongshan Hospital, Fudan University, Chief Physician of the Emergency Department, and a Ph.D. supervisor.

Dr. Song serves as Director of Shanghai Emergency and Critical Care Clinical Medical Research Center, Deputy Director of Shanghai Key Laboratory of Pulmonary Inflammation and Injury, Deputy Director of the 9th Youth Committee of Emergency Medicine Branch of Chinese Medical Association, Deputy Director of Emergency Medicine Branch of Chinese Medical Education Association. His main research areas are the pathogenesis of sepsis and acute lung injury.

Professor

Doctoral supervisor

Professor Liu is the Executive Vice Dean of the Intelligent Medicine Institute, Fudan University (in preparation), a fellow of the International Academy of Health Sciences Informatics (IAHSI), and Deputy Director of the Professional Committee of Clinical Data and Sample Resource Banks of the Chinese Research Hospital Association. He is also an Executive Member of the Chinese Society of Medical Informatics, among other roles.

His research areas include:

Biomedical Big Data: Developing big data platforms that integrate clinical data, biobank information, and omics data; text mining; structuring clinical data; biomedical big data mining.

Medical Artificial Intelligence: Constructing biomedical knowledge bases and developing ontologies; developing AI systems for medical imaging; developing clinical decision support systems.

Bioinformatics: Analyzing omics data, transcriptome data analysis, regulatory network analysis, systems dynamics modeling, and sequencing analysis.

Professor

Doctoral Supervisor.

Professor Lian is a Chair Professor at Shanghai Jiao Tong University, a professor in the School of Electronic Information and Electrical Engineering. He is a Fellow of the Canadian Academy of Engineering, the Singapore Academy of Engineering, and the American Institute of Electrical and Electronics Engineers (IEEE). He is also a member of the Disciplinary Group of Integrated Circuit Science and Engineering of the Academic Degrees Committee of the State Council, the co-editor-in-chief of the new high-level journal "Integrated Circuits and Systems" under China's Excellence Action Plan for Scientific Journals, and the Chairman of the Technical Committee of Shanghai Intelligent Pediatric Clinical Diagnosis and Treatment Technology Engineering Research Center.

Professor Lian mainly engages in research on integrated circuit design and digital signal processing, and he is recognized as an international pioneer in the field of biomedical circuits and systems. Over the past 25 years, he has dedicated himself to the research of ultra-low-power fully integrated wireless biomedical sensor chips and has successfully developed several world-first ultra-low-power wearable and implantable medical device chips, including chips for ECG, EEG, respiratory, and lung imaging devices.

Dr. Wang, Ph.D. in Surgery, Professor, Chief Physician, Doctoral Supervisor, and a Super Expert in Zhejiang Province, currently serves as the President of the Second Affiliated Hospital of Zhejiang University School of Medicine, Leader of the Hepatopancreatobiliary Surgery Discipline, and Director of the Organ Transplantation Center. He is also the Vice Dean of Zhejiang University School of Medicine, an Honorary Professor at the University of Hong Kong, an Honorary Fellow of the College of Surgeons of Hong Kong, and a Qiushi Distinguished Physician of Zhejiang University. He receives a special government allowance from the State Council and is recognized as a young and middle-aged expert with outstanding contributions by the National Health Commission.

Additionally, he holds several key positions, including Director of the Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Hepatopancreatobiliary Tumors; Director of the Zhejiang Provincial Research Center for Liver Cancer Diagnosis and Treatment Technology; Director of the Zhejiang Provincial Clinical Medical Research Center for Hepatopancreatobiliary Diseases; Director of the Precision Diagnosis and Treatment Innovation Center for Hepatopancreatobiliary Diseases at Zhejiang University; Director of the Institute of Surgery at Zhejiang University; and Director of the Zhejiang Provincial Engineering Laboratory for Medical Artificial Intelligence.

He also serves as Vice President of the China Hospital Association, a Standing Committee Member of the Surgery Branch of the Chinese Medical Association, a Standing Committee Member of the Branch of Organ Transplantation of the Chinese Medical Association, Chair of the Expert Committee on Enhanced Recovery After Surgery (ERAS) of the National Health Commission, Chair of the ERAS Expert Committee of the Chinese College of Surgeons under the Chinese Medical Doctor Association, and Chair-Elect of the Tumor Surgery Branch of the Zhejiang Medical Association.

His research focuses on liver transplantation and pediatric living donor liver transplantation, precision diagnosis and treatment of hepatopancreatobiliary tumors, medical artificial intelligence, and the development and translation of novel nanomedicines.

Dr. Chen is a senior member of the American College of Chest Physicians, a mid-to-young expert with outstanding contributions recognized by the Ministry of Public Health, a National Outstanding Scientific and Technological Worker, former director of the Guangzhou Institute of Respiratory Health, and the current director of the Shenzhen Institute of Respiratory Diseases. He also serves as the deputy director of the State Key Laboratory of Respiratory Disease, vice chairman and secretary general of Respiratory Disease Branch of the Chinese Medical Association and Head of the Respiratory Therapy Group. Additionally, he is the former chairman of the Respiratory Disease Branch of the Guangdong Medical Association, deputy editor of the Chinese Journal of Biomedical Engineering and the International Journal of Respiration, and a member of the editorial board and standing committee for various journals including the Chinese Journal of Internal Medicine, and the Chinese Journal of Tuberculosis and Respiratory Diseases.

Dr. Yang currently serves as an Associate Chief Physician, an Associate Researcher at Zhongshan Hospital, Fudan University, a Deputy Director of the Shanghai Engineering Research Center of Internet of Things for Respiratory Medicine, a Deputy Director of the Internet of Medical Things Research Laboratory at the Shanghai Respiratory Research Institute, and a member of the International Association for the Study of Lung Cancer (IASLC) Early Detection and Screening Committee.

He has been supported by the National Natural Science Foundation of China, Fujian Province Outstanding Young Fund, and Shanghai Pujiang Talent Program, among others. He also led the development of 7 consensus guidelines in domestic and abroad, including the International Metaverse Medicine Guidelines, obtained 15 patents, and published 77 academic papers, including 45 in SCI-indexed journals with an impact factor of over 410, more than 1500 citations, and an h-index of 21. He pioneered in offering a course on Metaverse Medicine at Fudan University, a core general education course.

Dr. Jia is the Director of the Journal Center at Zhongshan Hospital, affiliated with Fudan University, and serves as the Editorial Director and Deputy Editor-in-Chief of Chinese Journal of Clinical Medicine and Metaverse in Medicine. Dr. Jia is also the Editorial Director of Clinical Cancer Bulletin (English Edition) and Health Promotion. 

Dr. Jia, as the principal author, has published a total of 26 academic papers in various journals, including SCI, CSSCI, Peking University Core, and Science and Technology Core. As the principal investigator, he has led two provincial and ministerial-level projects and one key project of an academic society. As the second principal investigator, he has led one project of the State Administration of Press, Publication, Radio, Film and Television of China. He also holds a series of academic positions, including Deputy Director of the Academic Work Committee of the society of china university Journals and Executive Director of the Shanghai Association of University Science and Technology Journals.

Ph.D.  Associate Professor in Computer Applications 

Professor Gao currently serves as a senior member of the China Computer Federation, an executive member of the CCF Technical Committee on Block Chain, a standing member of the CSIAM Activity Group on Blockchain, a standing member of the China Mobile Communications Association Metaverse Consensus Circle, a member of the Chinese Institute of Command and Control, a member of the expert consulting team for CICC Urban Brain and Social Comprehensive Governance, an expert of the CSA GCR Metaverse Technology Security Working Committee. He also serves as an external supervisor at Xi'an Jiaotong-Liverpool University, a corporate mentor for professional masters at Henan University of Technology, and a visiting professor and part-time supervisor for master students majored in Statistics at Shanghai University of Engineering Science. 

Professor Gao's main research areas are blockchain, metaverse, and digital transformation.

Charles A Powell, MD, MBA, is Professor of Medicine and System Division Chief for Pulmonary, Critical Care, and Sleep Medicine at the Icahn School of Medicine at Mount Sinai. 

Dr. Powell is CEO of the Mount Sinai Respiratory Institute LLC, which brings together leading expertise in diagnosing and treating all forms of respiratory illness and lung disease, including asthma, lung cancer, chronic obstructive pulmonary disease, interstitial lung disease, and bronchiectasis. He is past-President of the Fleischner Society and holds leadership roles in the International Society of Respiratory Disease. 

Dr. Powell’s primary Pulmonary Disease focus is on the research and treatment of lung nodules and cancer. Dr. Powell is funded by the National Institutes of Health (NIH), has published over 150 articles, and directs an NIH-funded translational sciences laboratory that examines the genomics of lung cancer. Dr. Powell’s particular area of interest is on deconvoluting the biology and genomics of early stage lung adenocarcinoma, for which recent advances have modified the diagnosis and approach to these tumors. He is an international expert in the diagnosis and management of drug induced lung injury in patients treated with advanced cancer medications such as antibody drug conjugates and immunotherapy.  He also directs research programs focused on applications of machine learning and artificial intelligence to advance the diagnosis and treatment of respiratory diseases.

Niels Chavannes is professor of family medicine, head of research and founder of the National eHealth Living Lab (NeLL) at the department of Public Health and Primary Care, Leiden University Medical Center, the Netherlands. He is also visiting professor at the Respiratory Research Institute of Zhongshan Hospital, Fudan University. 

Chair of eHealth Applications in Population Health Management, focused on the evidence base of digital healthcare solutions, by applying innovative ehealth methodology, guided by population health management.

Dr. Med. Christoph Thuemmler is Clinician at Helios Park Klinikum Leipzig and Professor of eHealth at Edinburgh Napier. He is specialist for General Internal Medicine, Geriatric Medicine, Emergency Medicine. He is a prime mover in healthcare innovation, drawing on his extensive research and medical work, and an internationally recognised expert in eHealth, IoT, smart pharma, e-connectivity, Industry 4.0, 5G.

Dr. Bai is a professor in the Department of Respiratory Medicine at the Second Affiliated Hospital of Army Medical University. She serves as the Deputy Chairman of the Lung Cancer Full-Course Management Committee of the China Lung Cancer Alliance, Deputy Chairman of the Lung Cancer AI Diagnosis Committee of the China Lung Cancer Alliance, a member of the Lung Cancer Working Committee of the Respiratory Physician Branch of the Chinese Medical Doctor Association, and a member of the Lung Cancer Group of the Respiratory Disease Branch of the Chinese Medical Association. She is also a peer review expert for the National Natural Science Foundation, an executive editorial board member of the Journal of Clinical Pulmonology, and a correspondent editorial board member of the International Journal of Respiratory Diseases.

Dr. Bai specializes in smoking control, diagnosis of pulmonary nodules, early screening and diagnosis of lung cancer, targeted therapy, immunotherapy, and personalized comprehensive management of advanced lung cancer. She has led and participated in five projects funded by the National Natural Science Foundation and one project funded by the Chongqing Natural Science Foundation. She has published over 40 papers, including 11 SCI-indexed articles as the first or corresponding author, and has co-authored six monographs.

Dr. Cao is a Young Researcher and Principal Investigator (PI). Dr. Cao primarily focuses on translational and precision medicine research for carbohydrate-based drugs and targeted anti-tumor therapies. He has published over 40 papers in high-impact SCI journals such as Nature Communications and Drug Resistance Updates. He holds 13 patents for new drug inventions, authorized in China, the United States, Japan, Europe, Canada, and under the PCT. Dr. Cao has led several research projects funded by the National Natural Science Foundation of China, National Key Research and Development Program of China sub-projects, the Shanghai Natural Science Foundation, and the China Postdoctoral Science Foundation. In 2017, he was selected for the Youth Innovation Promotion Association by the Chinese Academy of Sciences, and in 2020, for Fudan University's "Excellence 2025" talent program. Dr. Cao received the Science Interdisciplinary and Innovation Award from the Youth Innovation Promotion Association of the Chinese Academy of Sciences in 2017 and the Third Prize for Academic Excellence from the Changmu Medical Foundation in 2019. He also serves as a member of the Oncology Drug Research Committee of the China Association of Traditional Chinese Medicine, a youth committee member of the Genetic Testing Technology Branch of the China Medicinal Biotechnology Association, a senior member of the Chinese Pharmaceutical Association, and a member of the Chinese Chemical Society. In the field of innovative drug research, Dr. Cao has completed the commercialization of two innovative drugs: "Carbohydrate-based Drug PL-201" and "Retinoid Anti-Tumor Drug WYC-209," with contract values totaling 28 million RMB.

Dr. Chen is a researcher at the Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, China. He serves as the Deputy Director of the Shanghai Science and Technology Novelty Search and Consultation Center of the Chinese Academy of Sciences and is recognized as a national patent information expert. He is an outstanding science and technology intelligence worker in the Yangtze River Delta region and a committee member of both the Synthetic Biotechnology Branch of the China Biotechnology Association and the Integrated Innovation Development Committee of the China Association of Technology Entrepreneurs. Additionally, he is an expert for the think tank at the Shanghai Technology Exchange and a member of the Standardization Technical Committee of the Shanghai Technology Market Association.

Dr. Chen's primary research focuses on science and technology intelligence. He has led his team in completing over 50 research projects in the fields of life and health sciences and interdisciplinary integration. These projects include sub-projects under the National Key Research and Development Program titled "Biosecurity Research in Synthetic Biology," a research project by the Bureau of Development and Planning of the Chinese Academy of Sciences on "Interdisciplinary Integration in the Field of Life Health," and a project by the Shanghai Science and Technology Committee on "Starting Points, Bottlenecks, and Challenges in the Development of Biomedicine, Integrated Circuits, and Artificial Intelligence Industries." He also worked on the Ministry of Commerce's "Industrial Security Monitoring Research in the Yangtze River Delta" and the Shanghai Municipal Commission of Commerce's "Shanghai Industrial Security Monitoring and Early Warning Research."

During his research, Dr. Chen developed the technology foresight analysis method based on knowledge lineage maps and the SMART assessment method centered on knowledge graphs. His work has led to five research achievements winning first or second prizes in the East China Science and Technology Intelligence Achievement Awards and eight winning first or second prizes in the Shanghai Science and Technology Awards. He has published over 20 papers in journals such as the Bulletin of the Chinese Academy of Sciences and Synthetic Biology, authored five books, and has been the main writer or participant in drafting two local standards.

Chen is an associate researcher at the Institute of Endocrinology and Metabolic Diseases, Zhongshan Hospital, Fudan University.

Dr. Chen is the Chief Physician of the Department of Pulmonary Medicine at Zhongshan Hospital, Fudan University. She serves as the Deputy Director of the Chronic Airway Diseases Subspecialty and is a Master's Supervisor. Dr. Chen is a member of the Pulmonary Function Group of the Respiratory Society of the Chinese Medical Association, a member of the Research Working Committee of the Chinese Medical Doctor Association, a member of the Respiratory Equipment Technology Committee of the Chinese Association of Medical Equipment, a member of the Asthma Group of the Respiratory Committee of the Shanghai Medical Association, and a member of the Respiratory Rehabilitation Branch of the Chinese Medical Education Association. Additionally, she is the Deputy Chairman of the Youth Committee of the Shanghai Respiratory Society.

With 16 years of clinical experience, Dr. Chen specializes in the diagnosis and treatment of chronic airway inflammatory diseases (such as chronic obstructive pulmonary disease, asthma, bronchiectasis, bronchiolitis), diffuse interstitial lung diseases (including interstitial pneumonia, sarcoidosis, pulmonary vasculitis, interstitial lung disease secondary to rheumatic diseases, pulmonary fibrosis), pulmonary vascular diseases (such as pulmonary embolism, pulmonary hypertension), airway allergic diseases (such as allergic asthma, allergic rhinitis), and complex pulmonary diseases.

Fang serves as the General Manager of the Digital Health Department and the Director of the Smart Healthcare Innovation Center at the Shanghai Industrial Innovation Center of the China Academy of Information and Communications Technology (CAICT).

CMO & Strategy Director

With twelve years of extensive entrepreneurship in the medical industry, Gan has experience spanning hardware, software, and content ecosystem fields.

Dr. Ge is the Chief Physician of the Respiratory Department at Huadong Hospital, Fudan University, and a Master's Supervisor. She serves as a member of the Interstitial Lung Disease Group of the Respiratory Physicians Branch of the Chinese Medical Doctor Association, a member of the IoT Medical Professional Committee of the China Non-government Medical Institutions Association, a member of the Respiratory Chronic Disease Rehabilitation Group of the Respiratory Rehabilitation Professional Committee of the Chinese Association of Rehabilitation Medicine, a member of the Youth Editorial Board of Practical Geriatrics, a member of the Shanghai COPD Alliance, a youth member of the Respiratory Disease Committee of the Shanghai Medical Association, and a youth member of the Infection and Chemotherapy Committee of the Shanghai Medical Association.

Dr. Ge specializes in the comprehensive diagnosis and treatment of chronic airway diseases, lung tumors, and pulmonary infectious diseases, as well as in bronchoscopic techniques and mechanical ventilation support therapy. Her research focuses on lung injury and chronic airway diseases, and her findings have been presented and awarded at international conferences such as the Asian Pacific Society of Respirology (APSR) Annual Meeting, American Thoracic Society (ATS) Annual Meeting, and European Respiratory Society (ERS) Annual Congress. She has published 12 SCI articles in leading respiratory journals such as AJRCMB and Respiration, with a total impact factor of 33.551. Dr. Ge has led or participated in seven national, provincial, and municipal research projects, including those funded by the National Natural Science Foundation of China. She has received support from various talent programs, including the 38th Sasakawa Medical Scholarship, the Huadong Hospital Core Talent Program, the ATS MECOR International Course Training Program, and the Harvard University Global Clinical Scholars Research Training (GCSRT) Program.

Dr. He is a Senior Engineer, Doctor of Management, member of the CPC, Director of the Medical Union Center at the Shanghai Hospital Development Center, and Deputy Director of the Medical Business Department; Deputy Director of the National Health Information Sharing and Application Engineering and Technology Research Center; Chairman of the Shanghai Society of the China Medical Informatics Association; Standing Director of the Chinese Health Information Association; Vice-Chairman of the Healthcare Information Technology Committee of the China Society of Cardiothoracic and Vascular Anesthesiology; Vice-President of the Shanghai Internet of Things Industry Association; Vice-Chairman of the Information Management Committee of the Shanghai Hospital Association; Vice-President of the Shanghai Informatization Youth Talent Association; and External Expert for the Shanghai Municipal Finance Bureau, Economic and Information Commission, and Science and Technology Commission, among other social positions.

For over two decades, he has been deeply engaged in the digital construction of hospitals and the development of regional medical informatization projects. He led the construction of the Shanghai Medical Union Project, which enables the sharing of clinical diagnosis and treatment information among 38 municipal hospitals, demonstrating strong capabilities in integrating hospital information systems with the coordinated development of regional healthcare. He has organized and participated in the research and development of 42 major national, provincial, and ministerial-level projects as a project leader and principal researcher, published 46 papers in public journals, and authored 3 monographs.

Dr. Hu is the Chief Physician of the Department of Respiratory and Critical Care Medicine at Zhongshan Hospital, Fudan University, and the Shanghai Geriatrics Medical Center. She specializes in the diagnosis and treatment of complex pulmonary diseases, particularly in the diagnosis and treatment of lung nodules, lung cancer screening and early diagnosis, personalized precision-targeted and immunotherapy for lung cancer guided by molecular markers, interventional respiratory endoscopy techniques, and comprehensive management of comorbidities in lung cancer.

Dr. Hu is the Vice President and Chief Surgeon of Ruijin Hospital and a Professor of Surgery. He specializes in the clinical diagnosis and laparoscopic treatment of gastrointestinal tumors. He serves as a standing committee member of the Robotic and Laparoscopic Surgery Committee of Chinese Research Hospital Association and is a founding member of the Chinese Laparoscopic Gastric Cancer Surgery Research Group.

As the leader of the sixth batch of the Shanghai (Ruijin Hospital) medical team aiding Hubei, he led the team to be awarded the title of "Advanced Collective in COVID-19 Epidemic Prevention and Control Work in the National Health System." In 2020, he was recognized as an Advanced Worker in Shanghai.

Dr. Hu is a Chief Physician, a member of the Primary Respiratory Group of the Respiratory Branch of the Chinese Medical Association, and a member of the Sleep Respiratory Disorders Working Committee of the Respiratory Branch of the Chinese Medical Doctor Association, among other affiliations.

Dr. Hu specializes in the diagnosis and treatment of diseases such as pulmonary malignancies, bronchial asthma, chronic bronchitis, chronic cough, sleep apnea syndrome, and functional respiratory disorders. He is particularly skilled in using non-invasive positive pressure ventilation for the management of acute and chronic critical respiratory conditions. Dr. Hu has been recognized as a "National Advanced Individual in the Health System" and has received the "Locomotive Labor Medal" awarded by the National Railway Workers' Union. He has led multiple provincial and municipal research projects and has published over 20 academic papers.

Since 2011, Mr. Huang has held several positions at Shanghai United Imaging Healthcare Co., Ltd., including CEO of the CT Division, CEO of the Information Technology and Security Management Division, CEO of the U+ Division, CEO of the Ultrasound Division, CEO of the Digital Technology Industry Group, Senior Vice President of the company, and Head of Digital Business for United Imaging Technology Group Co., Ltd.

Mr. Huang has twenty years of experience in full-chain product management for high-end medical imaging equipment and medical digital products, encompassing planning, research and development, production, and sales.

At Shanghai United Imaging Healthcare Co., Ltd., Mr. Huang established a CT team that possesses complete research and development capabilities for core components, such as complete systems and detectors. This has led to the development and deployment of a comprehensive product line of over ten models ranging from 16-slice to 320-slice CT scanners.

As the Head of Digital Business for United Imaging Group, Mr. Huang focuses on the future healthcare landscape globally, integrating new technologies and concepts from the metaverse. He is dedicated to technological innovation and application in the healthcare field, with the vision of "making healthcare services accessible." He aims to build a new generation of smart twin hospitals characterized by pervasive accessibility, integration of digital and physical realities, and interactive experiences, creating a paradigm of future hospitals that provides an exceptional healthcare experience and promotes high-quality development in the healthcare industry.

Dr. Jiang is the Director of the First Affiliated Hospital of Xiamen University, Vice Dean of the School of Medicine at Xiamen University, a Xiamen City Top Talent, and a State Council Special Allowance Expert. He is also a Chief Physician, Professor, and Doctoral Supervisor. Dr. Jiang is a member of the Asian Society of Luminal Surgery, a committee member of the Thoracic Surgery Branch of the Chinese Medical Association, a member of the Standing Committee of the Chinese Association of Thoracic Surgeons, vice-chairman of the Fujian Thoracic Surgery Society, vice-chairman of the Fujian Thoracic Surgery Society of Integrative Medicine, vice-chairman of the Xiamen Medical Association, president of the Xiamen Medical Association, and chairman of the Xiamen Thoracic Surgery Society. He has been awarded the "San De Xing" Medical Award and the highest honor in Xiamen's medical community, the "Lin Qiaozhi Medal."

Dr. Jiang was a visiting scholar at the School of Surgery, University of Bologna, Italy, under the auspices of the State Education Commission. He currently serves as a member of the editorial board for the Chinese Journal of Minimally Invasive Surgery, Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, Chinese Journal of Laparoscopy, Journal of Laparoscopic Surgery, and Chinese Journal of Traditional Chinese Medicine.

He has been deeply involved in clinical work in thoracic surgery for many years and specializes in minimally invasive surgery. In the field of thoracic surgery, Dr. Jiang was the first in the Xiamen area to perform radical lung cancer surgery, lobectomy with main bronchial sleeve plasty, tracheal tumor resection, three-field lymph node dissection for esophageal cancer, radical pancreatic cancer surgery, lumpectomy combined with esophageal cancer radical surgery, lumpectomy for early-stage lung cancer, thymoma resection, and more.

Professor Jing is the Associate Dean of the School of Mathematics and the Director of the Intelligent Computing Center at East China University of Science and Technology in Shanghai, China. He holds the title of Professor and Doctoral Supervisor. Professor Jing has been selected for the National High-Level Talent Special Support Plan and is a Distinguished Professor under the Shanghai Eastern Scholar Program. He is recognized as a Shuguang Scholar of Shanghai and serves as the Chief Expert at the Academician (Expert) Workstation in Shanghai. He is listed among China's Highly Cited Researchers. Professor Jing is a board member of the International Brain-Computer Interface Competition Foundation, a member of the Young Scientist Award Review Committee of the International BCI Society, the Vice Chair of the Medical Neural Engineering Branch of the Chinese Society of Biomedical Engineering, and a Distinguished Expert of the Chinese Association of Automation. He is also the Associate Editor of several SCI journals, including the Journal of Neuroscience Methods, Cognitive Neurodynamics, and Frontiers in Neurorobotics, as well as the Executive Editor of Neural Networks, a top journal of the Chinese Academy of Sciences. Professor Jing also serves on the editorial board of the top BCI journal, Journal of Neural Engineering.

Professor Jing's main research interests are brain-computer interface technology, brain signal processing and recognition, and intelligent rehabilitation robots. He has published over 160 papers in top BCI and CAS journals, including 12 highly cited ESI papers and one hot paper. Over the past five years, Professor Jing has led more than 20 national and provincial projects, including the National Key R&D Program of China (2030 Major Project), Shanghai's Major Scientific and Technological Projects, and the National Natural Science Foundation of China projects. His translational research achievements have received the China Medical Device Registration Certificate and CE certification in the European Union, and he has been nominated for the Austrian National Innovation Award.

Dr. Leng is a Chief Physician with a Ph.D., a renowned expert in ophthalmology at the National Children's Medical Center, Beijing Children's Hospital, Capital Medical University, and also serves as the Director of Ophthalmology at the Shunyi Branch.

Dr. Leng specializes in the surgical treatment of complex cataracts, lens dislocations, refractory glaucoma, and complex eye trauma reconstruction in both adults and infants. He has completed over 50,000 intraocular surgeries. In 2010, he was appointed by the Talent Exchange Center of the Ministry of Health as a cataract surgery training instructor. As one of the primary contributors, he has been involved in the National Science and Technology Support Program for promoting suitable techniques in rural areas. He has participated in nine medical aid missions to Tibet and six to Xinjiang. He is also a Beijing Hospitals Authority talent development project participant and a young backbone talent at Beijing Children's Hospital. In 2019, he was named a Medical Star of Beijing Children's Hospital.

Dr. Leng holds various positions, including Deputy Director of the Ophthalmology Group of the Middle-aged and Elderly Disease Working Committee of the China Anti-Aging Promotion Association, Member of the Ophthalmic Health Group of the Chinese Medical Doctor Association Adolescent Health and Medicine Committee, Member of the Ophthalmology Branch of the China National Health Association, Council Member of the Ophthalmology Specialty Branch of the Beijing Medical Doctor Association, Member of the Cataract Group of the Beijing Medical Association, and Member of the Glaucoma Committee of the Beijing Medical Doctor Association.

Dr. Leng has led four research projects and published 11 articles as the first author in SCI-indexed and core journals. He has received a first prize for new technological achievements at the provincial and ministerial levels as the primary contributor.

Dr. Li is an associate professor and the associate director of the Department of Forensic Medicine at the School of Basic Medical Sciences, Fudan University. He is also a doctoral supervisor and a recipient of the National Excellent Youth Fund.

He served as the Deputy Secretary-General of Distance Education Branch of Chinese Medical Association for Nationalities, the Secretary-General of Shanghai Forensic Medical Association, and a member of the Forensic Pathology Committee of Shanghai Forensic Association. In the past five years, he has published more than 30 papers in Circulation, STTT, Sci Transl Med, Pharmacol Res, Br J Pharmacol, Int J Legal Med and Forensic Sci Int, as the first or corresponding author (including co-corresponding authorship). These papers systematically explain the cardiac pathological changes and myocardial toxicological mechanisms caused by common antipsychotic drugs and establish a forensic identification strategy for sudden death.

He has led four projects funded by the National Natural Science Foundation of China and two projects funded by the China Postdoctoral Science Foundation. He has received the MCE China Life Science Research Promotion Award, the European Toxicology Society Young Scientist Nomination Award, and the Excellent Thesis Award from the Chinese Toxicology Society, the Chinese Forensic Medicine Society, and the Oriental Heart Association.

His research focuses on the toxicology and transformation of neuropsychiatric drugs, and the pathology, toxicology, and genetic mechanisms of unexplained sudden death.

Dr. Lu is the Director of the Department of Respiratory and Critical Care Medicine at The Fifth People's Hospital of Chongqing, a Chief Physician, and an Associate Professor.

Dr. Lu serves as a member of the Sleep Respiratory Disorders Working Committee of the Chinese Medical Doctor Association Respiratory Physician Branch, a member of the Sleep Respiratory Disorders Group of the Chinese Medical Association Respiratory Diseases Committee, a member of the Sleep Working Development Committee of the China Sleep Research Society, and the leader of the Sleep Respiratory Disorders Group of the Respiratory Diseases Branch of the Chongqing Medical Association.

Dr. Lu previously worked for over 20 years in the Respiratory Department of Xinqiao Hospital of Army Medical University. He specializes in the diagnosis and treatment of critical respiratory conditions and the management of chronic respiratory diseases, with extensive clinical experience in treating sleep respiratory disorders such as sleep apnea and obesity hypoventilation, especially when combined with insomnia. Dr. Lu has led and participated in numerous national and provincial research projects, including those funded by the National Natural Science Foundation of China and the China Postdoctoral Science Foundation, and has received a Chongqing Science and Technology Achievement Award.

Professor

Chief Physician

Doctoral Supervisor

Dr. Ma serves as a Committee Member and Vice President of the Affiliated Hospital of Guilin Medical College. He is recognized as a leading young talent in Guangxi Province and a top talent in Guilin City.

He currently serves as an expert reviewer for master's and doctoral theses under the Ministry of Education, a project reviewer for the National Natural Science Foundation, and an editorial board member of the National Medical Journal of China. He is also involved as a youth member of the Chinese Thoracic Society, a member of the Chinese College of Allergy and Asthma, a standing committee member of the Diagnostics Committee under China Medicine Education Association, and a standing committee member of the Vaccine and Health Branch of China Health Culture Association. Additionally, he holds vice-chair positions in several branches of the Guangxi Medical Association and the Guangxi Medical Doctors Association, including those related to internal medicine, respiratory diseases, respiratory endoscopy, and respiratory disease prevention and control, among others.

He has led four projects funded by the National Natural Science Foundation, three by the Guangxi Natural Science Foundation, and three Guangxi educational reform projects. As the first or corresponding author, he has published over 30 papers in SCI journals and has authored or co-authored eight books. He has received numerous awards, such as the "National Outstanding Instructor for Resident Standardization Training", "Guangxi Model Teacher", and "Most Beautiful Science and Technology Worker in Guilin". His clinical expertise includes the diagnosis and treatment of asthma, chronic obstructive pulmonary disease, pulmonary nodules, lung cancer, acute and chronic cough, respiratory infections, and respiratory endoscopy interventions.

Dr. Qi is the Dean of the Fudan University Institute for Artificial Intelligence Innovation and Industry (AI3) and the Dean of the Shanghai Institute for Science and Intelligence. He also serves as the Vice President of Taobao (China) Software Co., Ltd.

Previously, Dr. Qi led the development of Alibaba's first large-scale distributed machine learning platform, which won Alibaba's highest technical award in 2015. He also led the construction of Ant Group's ultra-large-scale graph neural network learning and privacy computing platforms, with the graph neural network learning platform winning the first prize of the Wu Wen Jun AI Science and Technology Award, the highest award in China's AI technology.

His research areas include large-scale machine learning, deep learning, Bayesian inference, and probabilistic graphical models, as well as bioinformatics, genomics, proteomics, brain image analysis, intelligent risk control, intelligent marketing, and search and recommendation systems.

Shen is the deputy secretary of the Shanghai Artificial Intelligence Industry Association.

Professor Sheng currently serves as the Deputy Director and Doctoral Supervisor at the Institute of Computer Applications, Shanghai Jiao Tong University. He has received funding from the National "Ten Thousand Talent Program", the Shanghai Pujiang Talent Program, among others. He has served as the Chairman of the ISBI2020, MICCAI2022, and MICCAI2023 International Fundus Image AI Reading Competitions, a member of the National Standardization Technical Committee (SAC/TC68), the Managing Editor of The Visual Computer, and Associate Editor for three SCI-indexed international journals in the field of computer applications, including IEEE Transactions on Circuits and Systems for Video Technology and The Visual Computer, as well as a Chinese journal on virtual reality - Virtual Reality and Intelligent Hardware (VRIH). In the past five years, he published 69 SCI/SSCI papers in journals such as Nature Medicine, Nature Communications, IJCV, IEEE TPAMI, IEEE TVCG, and IEEE TIP, and 63 conference papers for IEEE Virtual Reality, ICCV, MICCAI, and ACM Multimedia. He has received the Shanghai Science and Technology Progress Special Award in 2020, the SAIL AWARD at the World Artificial Intelligence Conference (twice), and the Distinguished Contribution Award from the Computer Graphics Society among other honors.

Dr. Shi is a Chief Physician in the Department of Liver Surgery at Zhongshan Hospital, Fudan University, an Associate Professor, and a Master's Supervisor. He also serves as a member of the Liver Metastasis of Colorectal Cancer Committee of the Chinese Anti-Cancer Association, a Youth Committee member of the Oncology Branch of the Chinese Medical Association, Vice President of the Alumni Association of Shaoxing University, an expert reviewer for the National Natural Science Foundation of China, a reviewer for journals such as Hepatology, Journal of Hepatology, and Cancer Research, and an editorial board member for Annals of Translational Medicine.

Dr. Song is the President and Chairman of the Shanghai Artificial Intelligence Research Institute and the Director of the AI Technology Center at the National Science Center for Translational Medicine (Shanghai). He also serves as the Deputy Secretary-General of the Global University Academic Alliance on Artificial Intelligence, Vice President of the Asian Alliance for Science and Technology for Sustainable Development, a member of the National Artificial Intelligence Standardization General Group, a member of the National Navigation Equipment Standardization Technical Committee, a member of the General Artificial Intelligence National Security Working Group, and a leading scientist in Huawei Ascend AI.

He has been awarded the Gold Medal at the Geneva International Exhibition of Inventions, the First Prize for Provincial and Ministerial Scientific and Technological Achievements, the Outstanding Scientific and Technological Achievement Award from the Chinese Association for Artificial Intelligence, the Science and Technology Progress Award, and the Leading Talent in Scientific and Technological Innovation award from the China Intelligent Transportation Association. Additionally, he has been recognized as an Outstanding Talent in the National Independent Innovation Demonstration Zone, a Leading Talent in the "Shanghai Industry Elite" program, and a "Pioneering Leader" in Shanghai's Digital Transformation.

Dr. Song is the Director of the Respiratory and Critical Care Medicine Department at Zhongshan Hospital, Fudan University. He is a specially-appointed professor by the Shanghai Education Commission, an Eastern Scholar, and a doctoral supervisor. He holds positions as an outstanding academic leader and leading talent in Shanghai. Additionally, he serves as the Vice Director of the Shanghai Respiratory Research Institute, Executive Committee member of the  Respiratory Branch of the Chinese Medical Association, and Standing Committee member of the Chinese Physicians Association Respiratory Physicians Branch. Dr. Song is also the Chairman of the Shanghai Respiratory Society and Director of the Shanghai Key Laboratory of Pulmonary Inflammation and Damage. He serves as Associate Editor for Respirology, Editor-in-Chief for The Clinical Respiratory Journal, and Editor-in-Chief for AJP-lung. He has applied for 8 patents, with 3 successfully transferred. Dr. Song specializes in treating COPD, bronchiectasis, pulmonary infections, and acute and chronic respiratory failure. He has led 17 projects including key research and development by the Ministry of Science and Technology, key projects by the National Natural Science Foundation, 973 sub-projects, and major projects by the Shanghai Municipal Science and Technology Commission. Dr. Song has published over 200 SCI papers in journals such as JAMA-Internal Medicine, Thorax, AJRCCM, and CCM, cited over 20,000 times. He has contributed to the editing of 8 books including Practical Internal Medicine, national graduate textbooks, and undergraduate textbooks. He was awarded the Shanghai Medical Award (Second Prize), Scientific and Technological Progress Award (Second Prize), and Chinese Medical Award (Third Prize).

Dr. Su is the director of the Department of Respiratory and Critical Care Medicine of Kunshan Hospital of Chinese Medicine, as well as a chief physician and medical doctor.

He served as a member of the Respiratory Rehabilitation Professional Committee of the Jiangsu Provincial Rehabilitation Medical Association, a member of the Sleep-disordered Breathing Group of the Respiratory Physicians Branch of the Jiangsu Provincial Medical Association, a member of the Respiratory Intervention Oncology Professional Committee of the Suzhou Cancer Society, a member of the Sleep Medicine Professional Committee of the Suzhou Medical Association, and a member of the Editorial Board of the Journal of Clinical Research and Practice. He has published more than ten academic works.

Dr. Sun is the Executive Vice President of the Shanghai Geriatrics Center and has long been engaged in medical quality and safety management, emergency medical services, and hospital accreditation and assessment. He has been selected as an expert in national and Shanghai accreditation and assessment groups. Dr. Sun possesses extensive research and practical experience in hospital management, medical process reengineering, and the construction and optimization of medical information systems, as well as in big data and artificial intelligence.

Dr. Wang is an Associate Researcher and Ph.D. supervisor at the School of Data Science, Fudan University. He received his Ph.D. from the Department of Electrical and Computer Engineering at Korea University in 2013. He has conducted teaching and research at Rutgers University, Duke University, and Seoul National University. In recent years, he has published over 50 papers in top-tier journals and conferences in the information field, such as IEEE TIT, IEEE TKDE, and IEEE TSP. Several of his papers have been selected as IEEE TSP Hot Papers, ESI Highly Cited Papers, and ESI Hot Papers, with over 800 citations in SCI. He has received nominations for the IEEE Signal Processing Society Best Young Author Paper Award, among other honors. He has undertaken projects funded by the National Natural Science Foundation of China, including general and key projects. He serves as a reviewer for IEEE TIT and Mathematical Reviews, and as an editorial board member for IEEE ACCESS, Frontier in Signal Processing, DCN, Applied Science, and other journals. Additionally, he is an expert reviewer for key research programs under the Ministry of Science and Technology and platforms under the Ministry of Industry and Information Technology.

His main research interests include graph neural networks, vision and autonomous driving, statistics and deep learning, and sparse and low-rank optimization.

Dr. Wang is the Vice President, Deputy Party Secretary, and President of the Fourth Affiliated Hospital, Zhejiang University School of Medicine, as well as the Party Secretary for both the Fourth Affiliated Hospital and the International Medical School of Zhejiang University. He has received numerous honors, including the National Science and Technology Progress Award (Second Prize), the Ministry of Education Science and Technology Progress Award (First Prize), Zhejiang Provincial Science and Technology Progress Award (First Prize), and recognition as one of Zhejiang Province’s Top Ten Outstanding Youths.

Dr. Wang serves as an editorial board member for Cancer Letters, Chair-Elect of the Respiratory Medicine Branch of the Zhejiang Medical Association, Chair-Elect of the Lung Cancer Professional Committee of the Zhejiang Provincial Anti-Cancer Association, Vice Chair of the Lung Cancer Professional Committee of the China Medical Education Association, and a member of the Lung Cancer Group of the Respiratory Medicine Branch of the Chinese Medical Association.

Chief Physician

Master's Supervisor

Dr. Wang is the Deputy Director of the Department of Respiratory and Critical Care Medicine at the Second People's Hospital of Wuxi and the Deputy Secretary of the Communist Party of the First Clinical Branch, Jiangnan University Medical Center.

Dr. Wang is a Chief Physician, specializing in the diagnosis and treatment of diseases such as pulmonary nodules, lung tumors, and complex pulmonary infections. Her main research interests include the clinical and basic research of personalized comprehensive treatment of lung cancer. Wang has unique insights into the diagnosis and treatment of complex and critical diseases, such as chronic cough-asthma syndrome, pulmonary interstitial disease, complicated respiratory infections, respiratory failure, and sleep apnea syndrome. She is proficient in airway intervention techniques such as tracheoscopy and thoracoscopy and is adept at applying artificial intelligence and 3D printing technologies in the field of respiratory medicine.

Dr. Wang has published 15 papers in SCI journals including Cancer, Respirology, Critical Care Medicine, European Respiratory Journal, Biomedicine & Pharmacotherapy, International Immunopharmacology, and European Respiratory Review, accumulating an impact factor of 155 and over 600 citations. She has contributed to the global expert consensus on COVID-19, holds 3 authorized patents, 5 software copyrights, and has authored 1 monograph.

Dr. Wang has participated in 10 national-level scientific research projects, including key projects funded by the National Natural Science Foundation of China. She currently serves as a committee member of the Jiangsu Medical Association Respiratory Branch, a member of the Foreign Affairs Committee of the Chinese Medical Doctor Association, a standing committee member of the Intelligent Medicine Committee of the China Medicine Education Association, the Vice-Chairman of the Professional Committee of Translational Medicine of China Microcirculation Society (Youth Working Committee), and a member of the Professional Committee on Intelligent Technology Applications under Association of Fundamental Computing Education in Chinese Universities.

Dr. Wang is a Chief Physician in the Department of Pulmonary Medicine at The First Affiliated Hospital, Zhejiang University School of Medicine. Clinically, she specializes in interventional diagnosis and treatment using bronchoscopy and endobronchial ultrasound, precision treatment of lung cancer, standardized comprehensive management, diagnosis and standardized follow-up of pulmonary nodules, and diagnosis of complex pulmonary diseases.

Dr. Wei is the Deputy Director and Chief Physician in the Department of Respiratory and Critical Care Medicine at The First People's Hospital of Nanning. He holds a Doctorate in Medicine and serves as a master's supervisor. He is recognized as one of Nanning's top technical talents (10th batch) and holds several key positions, including Vice Chairman of the first committee of the Guangxi Hospital Medical Management Professional Committee, Standing Committee Member of the Guangxi Medical Association Respiratory Disease Branch, Standing Committee Member of the Guangxi Medical Association Internal Medicine Branch, Committee Member of the Guangxi Anti-Cancer Association Lung Cancer Professional Committee, and Committee Member of the Guangxi Medical Association Respiratory Endoscopy Physicians Branch.

With 20 years of experience in respiratory clinical work, Dr. Wei is proficient in the clinical application of bronchoscopy and medical thoracoscopy, as well as the diagnosis and treatment of common and frequently occurring diseases in respiratory medicine, and the rescue of acute and critical respiratory conditions. In 2020, he was honored with several national and regional awards for his contributions to COVID-19 pandemic prevention and control, including the titles of "Advanced Individual in the National Health System COVID-19 Prevention and Control," "Advanced Individual in the National Fight Against COVID-19," "Advanced Worker of the Guangxi Zhuang Autonomous Region," and recognition as a member of the first group commended for COVID-19 prevention and control in Nanning. In June 2021, he was awarded the title of "National Outstanding Communist Party Member" by the Central Committee of the Communist Party of China. Dr. Wei is also a representative of the 12th Party Congress of the Guangxi Zhuang Autonomous Region and a deputy to the 14th People's Congress of the Guangxi Zhuang Autonomous Region.

His main research interests include pulmonary malignancies, pulmonary embolism, and interventional respiratory therapy.

Dr. Wei is the Deputy Director of the Department of Thoracic Surgery at the Second Affiliated Hospital of Nanchang University, a Chief Physician, Professor, and Doctoral Supervisor. His clinical focus is on early lung cancer screening and minimally invasive thoracoscopic surgery, with expertise in minimally invasive thoracic surgery and mass spectrometry analysis for the early diagnosis of thoracic diseases. He was the first in the province to perform single-port thoracoscopic surgery, successfully applying minimally invasive techniques to traditional thoracic surgeries such as lung cancer resection, lung sleeve resection, esophageal cancer resection, and mediastinal tumor removal. Dr. Wei is particularly skilled in single-port thoracoscopic surgery and the management of pulmonary nodules. He holds eight patents for minimally invasive thoracoscopic devices, including a pulmonary nodule localization device and a visualized thoracic puncture instrument. He has also authorized six patents for organizational technologies and developed one "automatic sputum mass spectrometry analyzer."

Dr. Wei has been awarded four National Natural Science Foundation of China grants, undertaken a national major scientific instrument and equipment development project, secured one key project from the Jiangxi Provincial Natural Science Foundation, and received a Jiangxi Provincial Distinguished Young Scholar Fund. He has led more than a dozen other provincial and departmental projects and has published over 100 academic papers in domestic and international journals.

Dr. Wei was recognized as an Advanced Individual in the fight against COVID-19 in Jiangxi Province and named a Labor Model in Suizhou, Hubei Province. He also serves as a member of the Thoracic Surgery Committee of the Chinese Medical Doctor Association, a standing committee member of the Lung Tumor Professional Committee of the China Medical Education Association, the Chair of the Youth Committee of the Thoracic Surgery Branch of the Jiangxi Research Hospital Association, a member of the Thoracic and Cardiovascular Surgery Branch of the Jiangxi Medical Association, the Secretary General of the Thoracic Surgery Branch of the Jiangxi Research Hospital Association, and the Secretary of the Jiangxi Branch of the Early Lung Cancer Screening Center of the Chinese Alliance Against Lung Cancer.

Dr. Hongyi Xin is currently an associate professor at the Global Institute of Future Technology (GIFT) at Shanghai Jiao Tong University. Before that, he was the "James-Wu-and-Jane-Sun" endowed associate professor at UM-SJTU Joint Institute. Hongyi received his PhD from the computer science department at Carnegie Mellon University, under the supervision of Carl Kingsford and had been a post-doc fellow at UPMC Children's Hospital supervised by Dr. Wei Chen.

Hongyi has been awarded multiple provincial and national grants from both NSFC and STCSM. He also holds multiple national and provincial awarded young talent titles.

Specialty: Information Technology, Metaverse in Medicine

Dr. Xue is the Deputy Director, academic leader, Associate Chief Physician, and Professor of the Department of Respiratory and Critical Care Medicine at Beijing Shijitan Hospital, affiliated with Capital Medical University. He is recognized as an outstanding young scholar and doctoral supervisor at Capital Medical University, and has been honored with titles such as Beijing Outstanding Young Talent, Beijing Top Young Talent, and Taishan Scholar, etc.

Dr. Xue primarily focuses on clinical and mechanistic research of pulmonary fungal infections and lung tumors. He has published over 70 SCI papers as the first author or corresponding author (including co-authorship), with 12 papers having an impact factor greater than 10. He holds 18 national invention patents and has received more than 10 awards as the primary recipient, including the 24th National Patent Excellence Award and the Second Prize for Scientific and Technological Progress by the Ministry of Education. Additionally, Dr. Xue serves as a member of the Chinese Medical Association for High Altitude Medicine, the Chinese Radiologist Association, the Chinese Antituberculosis Association for MDT, and the Chinese Alliance Against Lung Cancer.

Dr. Yang is the chief physician and a doctoral supervisor of respiratory medicine at Zhongshan Hospital, Fudan University.

He is committed to clinical and basic research on chronic airway diseases and lung injury. In recent years, he has focused on studying the immunology, metabolomics, and molecular pathogenesis of chronic obstructive pulmonary disease (COPD), as well as the intervention and management of COPD using artificial intelligence strategies. He has also conducted research on the molecular pathogenesis and potential therapeutic targets of lung injury.

Since 2017, Dr. Yang has published nearly 20 academic papers as the corresponding author or first author. He has undertaken two general projects funded by the National Natural Science Foundation of China, one sub-project of the National Key Research Plan of the Ministry of Science and Technology, one scientific research project in Shanghai, and two exploratory application projects related to artificial intelligence and the Internet of Things. Professor Yang has been invited to present reports and has won awards at international academic conferences, such as the annual conferences on respiratory diseases in the United States and Europe. His series of research results won the second prize at the 2020 Shanghai Medical Science and Technology Awards.

Associate Professor in the Department of Respiratory and Critical Care Medicine at The First Affiliated Hospital of Chongqing Medical University, Dr. Yang is primarily engaged in research on lung cancer, lung nodules, chronic respiratory diseases, respiratory infections, CT-guided percutaneous interventional diagnosis and early treatment techniques, artificial intelligence, and databases for respiratory diseases.

She has led 10 projects funded by the National Natural Science Foundation of China (NSFC), the National Cancer Center Youth and Middle-aged Fund, and key research and development projects at the provincial and ministerial levels. Dr. Yang has published more than 40 articles in Chinese and English as the first author or corresponding author, has been awarded 10 patents, software copyrights, and has contributed to the editing of 5 monographs.

Dr. Yang is the Deputy Chief Physician of the Neurosurgery Department at Zhongshan Hospital, Fudan University, and a Master's Supervisor. He has long been engaged in research on endovascular brain-computer interfaces, cerebrovascular interventional device development, and functional assessment of cerebrovascular diseases, with particular expertise in minimally invasive interventional surgery for various cerebrovascular conditions. He has participated in and led several national research projects and projects funded by the Shanghai Science and Technology Commission. Dr. Yang has published more than 20 papers, won the first prize in the Medical Achievement Award from the Ministry of Education of China and the first prize in the Medical Achievement Award from Shanghai Municipality. He has been awarded one national invention patent and seven utility model patents, has contributed to the editing of four monographs, and serves as a reviewer for World Neurosurgery and the Chinese Journal of Clinical Medicine.

Dr. Yu, Ph.D., is a Researcher and Doctoral Supervisor who currently serves as the Vice Dean of the Faculty of Medicine at The Chinese University of Hong Kong, Shenzhen, President of the National Health and Medical Big Data Research Institute (Shenzhen), President of the Second Affiliated Hospital of The Chinese University of Hong Kong, Shenzhen, Director of the Institute of Medical Information at the China Hospital Development Institute of Shanghai Jiao Tong University, Director of the Shanghai Pediatric Precision Medicine Big Data Engineering Technology Research Center, President of the Pediatric Infection and Immunology Research Institute at Shanghai Jiao Tong University School of Medicine, and Head of the Early Childhood Development Base at Shanghai Children's Hospital.

In 2020, he was selected for the "National Hundred, Thousand, and Ten Thousand Talents Project" and was recognized as an expert with outstanding contributions by the Ministry of Human Resources and Social Security. In 2014, he was approved to receive a special government allowance from the State Council and was named an Outstanding Discipline Leader in the Shanghai health system. In 2015, he was recognized as a Leading Talent in Shanghai, and in 2018, he was honored as an Outstanding Academic Leader in Shanghai. In 2021, his team was awarded the Collaborative Innovation Team title by the School of Medicine at Shanghai Jiao Tong University and received the Shanghai Government Children's Work Magnolia Award.

Zhang is the director of the Office of the Big Data Artificial Intelligence Center of Zhongshan Hospital, Fudan University.

Dr. Zhang has previously served as the General Manager of the China Division of a Fortune 500 company, a senior executive at a major domestic medical device company, and a senior advisor at a national-level high-end think tank. With 30 years of dedication to the medical device industry, Dr. Zhang has acquired extensive expertise in market access, marketing, corporate management, strategic planning, and industry consulting in China. He focuses on national health policies and explores the integration of next-generation communication technologies with the healthcare sector, committing to the promotion of new technologies in the medical field. Dr. Zhang has in-depth research and practical experience in areas such as smart hospitals, digital healthcare, medical artificial intelligence, and intelligent medical devices, including market access, commercial positioning, and business operation cycles.

Chief Nurse,

Clinical Professor

Doctoral Supervisor at Zhongshan Hospital, Fudan University

Currently serving as the Director of the Nursing Department at Zhongshan Hospital, Fudan University, and Deputy Dean of the School of Nursing at Fudan University, Zhang is also a Fellow of the American Academy of Nursing (FAAN).

She holds several key academic and professional positions, including: Chairman of the Nursing Professional Development Expert Committee of the "Belt and Road" Medical Talent Training Alliance at Health Human Resources Development center of the National Health Commission; Vice President of the Nursing Branch of the Chinese Research Hospital Association; Member of the Nursing Subcommittee of the China Modern Hospital Management Think Tank; Fifth-term Director and Vice Chair of the Nursing Branch of the China Hospital Education Association; Member of the National Clinical Academic Guidance Expert Committee for Nursing; Chairman of the Nursing Group of the Pediatrics Branch of the Chinese Medical Association; Chairman of the Nursing Subcommittee of the Shanghai Modern Service Industry Association; Vice Chairman of the Shanghai Modern Nursing Vocational Education Group; Vice Chairman of the Nursing Special Committee of the Shanghai Hospital Association.

In addition, Zhang serves as Deputy Editor of Shanghai Nursing, and is on the editorial boards of Chinese Journal of Nursing, Chinese Nursing Management, Chinese Nursing Education, Chinese Journal of Evidence-Based Pediatrics, and Journal of PLA Nursing. She is also a reviewer for Nursing in Critical Care and BMJ Open.

Her accolades include second and third prizes from the Chinese Nursing Association for scientific and technological progress, first prize for nursing scientific and technological progress in Shanghai, and recognition for excellent scientific projects by the Cross-Strait Medicine and Health Exchange Association Nursing Branch.

Dr. Zhang is the Director and Academic Leader of the Department of Respiratory and Critical Care Medicine at Fudan University Affiliated Pudong Medical Center. He is a Chief Physician, holds a Ph.D. in Medicine, and completed his postdoctoral training. He is also a doctoral supervisor at Fudan University and was selected for the Shanghai Pujiang Talent Program.

He serves as a standing committee member of the Minimally Invasive Respiratory Intervention Committee of the Chinese Medical Education Association, the Early Lung Cancer AI Diagnosis Committee of the China Lung Cancer Prevention and Control Alliance, the Respiratory Intervention Committee of the China Human Health Science and Technology Promotion Society, the Infectious Diseases Committee of the Shanghai Medical Association, and the Infectious Disease Management Committee of the Shanghai Hospital Association. He has published over 40 academic papers and holds 4 authorized national invention patents. Additionally, he has led more than 10 projects, including those funded by the National Natural Science Foundation of China and the Shanghai Science and Technology Committee.

Professor Zhao is a Researcher at the Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, and a Doctoral Supervisor. By combining advanced micro-nano processing technology with novel materials, and leveraging an interdisciplinary background in biomedical engineering, microelectronics, mechanical engineering, and neuroengineering, he has systematically developed tissue-compatible, long-term stable, large-scale flexible electronic neural interfaces. These interfaces are applied to research in basic neuroscience, brain disorders, and invasive brain-computer interfaces.

Dr. Zhou is the Executive Director and a member of the Party Committee of the Xiamen Branch of Zhongshan Hospital, Fudan University, the Deputy Director of the Radiology Department at Zhongshan Hospital, Fudan University, the Executive Director of the Radiology Department at the Xiamen Branch of Zhongshan Hospital, Fudan University, and the Sub-specialist Director of Retroperitoneal, Musculoskeletal, Urinary, and Reproductive Imaging. For many years, he has been working on the front lines of clinical practice, completing nearly 300,000 CT and MR report audits, and guiding experts in many tertiary hospitals in Jiangsu and Zhejiang provinces. Additionally, he is responsible for hospital research, discipline construction, clinical trials, education, resident and specialist training, continuing education, and information work. He oversees the Ministry of Science and Education, the Ministry of Information, the Institute of Clinical Medicine, and clinical trial institutions.

Currently, Shangming is the Director of NHS Kernow Datalab with the Centre for Health Technologyat the Faculty of Health: Medicine, Dentistry and Human Sciences. He is also an affiliated investigator with the Health Data Research UK (HDR UK). His research was funded by HDRUK, MRC, EPSRC, HCRW, Charities, and international collaborations.

Shangming’s research interests focus on AI and statistics in health and biomedical informatics: data-driven health-related studies using techniques, such as machine learning/deep learning, natural language processing, computational intelligence (artificial neural networks, fuzzy logic, nature-inspired computing etc), statistical analytics, and data mining.

Master's Supervisor

Professor Zhu is an Associate Professor in the School of Automation at Chongqing University of Posts and Telecommunications. He is a Bayu Youth Scholar of Chongqing, an executive member of the Industrial Control Computer Committee of the China Computer Federation, and a member of the Youth Working Committee of the Chinese Association for Artificial Intelligence. Holding a Ph.D. in Engineering, he was jointly trained by Chongqing University and Arizona State University. His main research areas include image processing, machine learning, intelligent control, and blockchain technology.

Medical Doctor,

Professor, Chief Physician,

Director of the Department of Anesthesiology at Naval Medical University

Dr.Zou, a leading figure in perioperative medical devices and sepsis research, has been recognized through numerous prestigious talent programs, including the 10th Shanghai Youth Science and Technology Talents, Shanghai Science and Technology Commission's Outstanding Technical Leader Program, Shanghai Talent Development Fund, the Science and Technology Commission's Rising Star Program, the Education Commission's Morning Light Program, and the Health Commission's New Excellent Youth Program.

He has led over 20 research projects, including those funded by the National Natural Science Foundation and the Shanghai Science and Technology Commission. With over 50 SCI papers published, Dr. Zou has received second-place awards from the military, Shanghai, and the Ministry of Education. He serves on several academic committees, including the Anesthesiology Branch of the Chinese Medical Doctor Association and the Shanghai Anesthesiology Society.